ENTX compared with ELTX: revenue, margins and what each company keeps, and the suppliers and customers both name

ENTXEntera Bio Ltd.

Mkt capRevenueRevenue

ELTXElicio Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ENTXEntera Bio Ltd.

ELTXElicio Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ENTX 1

OPKOPKO Healthsupplier

Shared 0

No shared counterparties.

Only ELTX 6

—Dr. Roberto Chiarleunlistedsupplier

—Gastro-Intestinal ("GI") Research Foundationunlistedsupplier

—Massachusetts Institute of Technology ("MIT")unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Memorial Sloan Kettering Cancer Centerunlistedsupplier

2 more · ELTX chain ›

ENTXEntera Bio Ltd.

3.00· pre 3.00· delayed

Mkt cap$150.8MRevenue$42,000Q1 FY25

ELTXElicio Therapeutics, Inc.

1.41· pre 1.36· delayed

Pre-marketNov 5 '26delayed

Mkt cap$41.0MRevenue—

Compare

Pre-marketNov 5 '26delayed

ENTXEntera Bio Ltd.

ELTXElicio Therapeutics, Inc.

3.00pre 3.00delayed

Price

1.41pre 1.36delayed

$150.8M

Mkt cap

$41.0M

Q1 FY25$42,000

Revenue

—

ENTX3.00vsELTX1.41Pre-marketNov 5 '26delayed